PATENT CLAIM ANALYSIS

Application Number: 16351457
Application Type: Utility
Filing Date: 2019-03
Publication Date: 2019-07
Patent Classification: ["514", "312000"]

Abstract:
The invention relates to inhibitors of mutant isocitrate dehydrogenase (mt-IDH) proteins with neomorphic activity useful in the treatment of cell-proliferation disorders and cancers, having the Formula: where A, B, U, V, Z, W 1 , W 2 , W 3 , and R 1 -R 6  are described herein.

Claim (Index 1):
A compound of formula I: or a pharmaceutically acceptable salt thereof, wherein: W 1  and W 2  are CH; W 3  is CR 2 ; U is N; V is CR 9 ; Z is C; B and R 9  are taken together with the atoms to which they are attached and form a 5 to 7-membered heterocyclyl or heteroaryl ring system which can be further substituted with one or more R 10  substituents; R 1  is halogen; R 2  is H; R 3  is H; R 4  and R 5  are independently H or C 1 -C 3  alkyl; R 6  is H; and R 10  is \u2014C(O)R 11 ; R 11  is C 1 -C 6  alkyl.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 99.0
- Lexical Diversity: 1.31111
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15568051', '15964812', '14858170', '15977512', '14858174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7953124378706086
- 35 USC 102 Novelty (BERT): 0.5562323423889916
- Combined Prediction Score: 0.7714044283224468
- Mean Citation Score: 397.399702
- Max Citation Score: 410.06107
- Similarity Product: 343.6729470638704

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test